OVERVIEW OF CONSENT FORM
The primary objective of this consent form is to provide the necessary information (in conjunction with the clinical consultation) to allow patients to make an informed decision and consent for Medicinal Cannabis (MC) treatment.
Further objectives of this treatment consent form are:
- To describe the benefits, risks, and possible complications of the treatment.
- To explain the patient’s/your responsibilities.
BENEFITS, RISKS, AND POSSIBLE COMPLICATIONS OF MEDICINAL CANNABIS
I acknowledge that:
- MC is generally considered an experimental or investigational drug and, in many cases, there is limited data from which to draw specific recommendations for treatment (for more information visit: https://www.tga.gov.au/medicinal-cannabis-guidance-documents).
- MC drugs are in general not registered in Australia by the Therapeutic Goods Administration of the Australian Department of Health and Ageing and have, therefore, not been tested for safety or efficacy.
- MC benefits and harms in children, pregnancy, and breast-feeding are not well investigated.
- I waive my rights to claim against the possibility of side-effects, risks, and unknown risks.
- MC may interact with my current medications and cause side effects from these medications.
- Possible side-effects of an MC treatment, especially with Tetrahydrocannabinol (THC), may include and are not limited to:
Asthenia (abnormal physical weakness or lack of energy), Confusion, Disorientation, Dizziness, Drowsiness, Vertigo, Sleepiness, Sedation, Balance problems, Coordination, Memory problems, Diarrhoea, Dry Mouth, Fatigue, Hallucinations, Anxiety, Paranoid thoughts, Increased appetite, Vomiting or Nausea, Cannabis use disorder, Cognitive impairment, Chronic bronchitis (if inhaled/smoked), Nausea, Light-headedness, Uncontrolled laughter or Euphoria.